In 2006, the research-and-development arm of Pliva was acquired by GlaxoSmithKline, which has ample resources for clinical trials, but the company has not commercialized the peptide
Lyophilized GHK-Cu is typically kept refrigerated and protected from light for short-term handling, and frozen (-20C) for longer-term storage
128 Radiographic studies, including X-rays and MRI, allow for precise measurement of the tibial slope and provide empirical data on its impact on ACL strain
In 2023, the FDA approved a longer-acting IL1 blocking medication called canakinumab (Ilaris) for use in special circumstances
this summary covers the well-studied copper tripeptide GHK-Cu (glycyl-L-histidyl-L-lysineCu)
However, there are no completed large-scale human clinical trials